Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.

Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.

Lim F, Hartley D, Starr P, Lang P, Song S, Yu L, Wang Y, Geller AI.

Biotechniques. 1996 Mar;20(3):460-9.

PMID:
8679207
3.

Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study.

Huang Q, Vonsattel JP, Schaffer PA, Martuza RL, Breakefield XO, DiFiglia M.

Exp Neurol. 1992 Mar;115(3):303-16.

PMID:
1311266
4.
5.

Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors.

Costantini LC, Jacoby DR, Wang S, Fraefel C, Breakefield XO, Isacson O.

Hum Gene Ther. 1999 Oct 10;10(15):2481-94. Erratum in: Hum Gene Ther 2000 Apr 10;11(6):981.

PMID:
10543613
7.

Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy.

Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, de Groat WC, Yoshimura N.

Diabetes. 2004 Oct;53(10):2723-30.

8.
9.

Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.

Jacobs AH, Winkeler A, Hartung M, Slack M, Dittmar C, Kummer C, Knoess C, Galldiks N, Vollmar S, Wienhard K, Heiss WD.

Hum Gene Ther. 2003 Feb 10;14(3):277-97.

PMID:
12639307
10.

Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.

Fraefel C, Jacoby DR, Lage C, Hilderbrand H, Chou JY, Alt FW, Breakefield XO, Majzoub JA.

Mol Med. 1997 Dec;3(12):813-25.

11.

Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction.

Goins WF, Yoshimura N, Phelan MW, Yokoyama T, Fraser MO, Ozawa H, Bennett N JR, de Groat WC, Glorioso JC, Chancellor MB.

J Urol. 2001 May;165(5):1748-54.

PMID:
11342969
12.
13.
14.
15.

Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.

Sortwell CE, Bowers WJ, Counts SE, Pitzer MR, Fleming MF, McGuire SO, Maguire-Zeiss KA, Federoff HJ, Collier TJ.

Brain Res. 2007 Feb 23;1134(1):33-44. Epub 2006 Dec 28.

16.

Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.

Goins WF, Lee KA, Cavalcoli JD, O'Malley ME, DeKosky ST, Fink DJ, Glorioso JC.

J Virol. 1999 Jan;73(1):519-32.

17.

Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.

Kramm CM, Rainov NG, Sena-Esteves M, Chase M, Pechan PA, Chiocca EA, Breakefield XO.

Hum Gene Ther. 1996 Feb 10;7(3):291-300.

PMID:
8835217
18.

Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector.

Johnson PA, Yoshida K, Gage FH, Friedmann T.

Brain Res Mol Brain Res. 1992 Jan;12(1-3):95-102.

PMID:
1312210
19.

Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants.

Chiocca EA, Choi BB, Cai WZ, DeLuca NA, Schaffer PA, DiFiglia M, Breakefield XO, Martuza RL.

New Biol. 1990 Aug;2(8):739-46.

PMID:
2178004
20.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.

Cancer Res. 2001 Apr 1;61(7):2983-95.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk